Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most people, tiredness on Mounjaro is tied directly to dose changes and tends to settle within one to two weeks. It is one of the more common early side effects, driven by the way tirzepatide shifts your appetite and energy balance — but it rarely stays at peak intensity for long. These are prescription-only medicines; a prescriber reviews your health picture before and during treatment to help manage effects like this. Understanding the typical timeline, and knowing when fatigue is signalling something that needs attention, is what this page covers.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tiredness tends to arrive early. Within the first few days of starting tirzepatide, or of moving up to a new strength, your body is responding to a significant shift in gut-hormone signalling: gastric emptying slows, appetite drops sharply, and calorie intake often falls before people have consciously adjusted their meals. That combination (lower fuel, less hunger to prompt eating, a digestive system working differently) can leave you feeling genuinely drained.
The NHS tirzepatide medicines page lists tiredness and fatigue among the common side effects of Mounjaro, alongside nausea and digestive changes. Most people find this phase peaks around days three to five and then softens. By the end of the second week at a given dose, fatigue has typically settled for the majority of patients. It does not mean the treatment is not working, it usually means it is.
A practical note: if your pen lives in the fridge door, pairing your weekly injection with a consistent day and a proper meal shortly after can help you keep track of when any tiredness peaks and fades. That pattern is useful information to share with your prescriber.
If you are still feeling persistently fatigued three weeks into a stable dose, something else may be contributing. The most common culprits are straightforward: not eating enough protein (which affects muscle and energy), inadequate hydration (often underestimated when nausea reduces fluid intake), or poor sleep from GI discomfort. Our overview of Mounjaro fatigue covers why appetite suppression can be powerful enough that people unintentionally under-fuel themselves for weeks, with fatigue often the first sign.
You can read more about the broader pattern of how long side effects typically run on our guide to Mounjaro side effect duration, which covers the full picture across dose stages. The key question to ask yourself at week three or four is whether your fatigue is trending downward (even slowly) or holding steady. Slow improvement is normal. No improvement at all is a reason to check in with your prescriber rather than wait it out alone.
Iron-deficiency anaemia and thyroid changes are unrelated to Mounjaro but can produce almost identical fatigue; if you have been losing weight rapidly and tiredness is dominant, your GP may want to run bloods. That is a clinical decision, not one to make from a search result.
Most Mounjaro fatigue is benign and self-limiting. Some fatigue, though, is a flag for something that needs prompt attention. You should seek medical help without delay if tiredness is accompanied by: severe or persistent stomach pain that spreads to your back (which may, rarely, indicate pancreatitis, the MHRA issued a Drug Safety Update on GLP-1 medicines and acute pancreatitis in January 2026, confirming it as an infrequent but serious risk); signs of significant dehydration from vomiting or diarrhoea (dizziness, very dark urine, inability to keep fluids down); or an allergic reaction such as swelling, rash or breathing difficulty.
Fatigue alone, without these accompanying symptoms, is unlikely to be an emergency. But "unlikely" is not the same as "ignore it". Our prescribers are available for aftercare seven days a week, getting in touch takes less time than a GP appointment, and a quick conversation can either reassure you or catch something worth acting on. The MHRA Yellow Card scheme is also open to patients who want to report fatigue or any other suspected side effect directly to the regulator.
There is no fix that overrides the adaptation phase, but several things consistently make it shorter and milder. Protein at every meal (even small ones) helps preserve lean mass and energy during the appetite-suppressed early weeks. Fluids matter too; it is easy to slip into mild dehydration when nausea makes drinking feel unappealing. Rest, where you can take it, is not laziness; it is your body spending energy on adjustment.
Some people find fatigue tracks closely with their GI symptoms. Our page on how long digestive side effects last on Mounjaro covers that side of the picture in more detail. Hair thinning, which sometimes appears later in treatment and is related to rapid weight loss rather than the medicine itself, has its own separate pattern, covered on our hair loss duration page.
Mounjaro is a dual GIP and GLP-1 receptor agonist, the only licensed weight-loss medicine in the UK to work across both pathways. If you want a closer look at whether tirzepatide is directly responsible for your tiredness, our page on whether Mounjaro causes fatigue works through the evidence in detail. If you are considering treatment and want to talk through how side effects like tiredness are monitored and managed, a free consultation with our prescribers is the place to start. They discuss suitability and side effects as a core part of the clinical assessment, not an afterthought.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.